Arcutis Biotherapeutics EVP, CMO Burnett sells $394,896 in stock — See source for full details.
$ARQT
Price history, market instrument context, member research, and related headlines in one place.
ARQT key statistics
NasdaqGSUSD
52-week range
$19.3075%$31.77
Latest session $26.93–$28.65Arcutis Biotherapeutics, Inc. (ARQT) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $28.62, up $2.21 (8.37%) from the previous close of $26.41. It has traded between $26.93 and $28.65 in the latest session. Over the past year it has ranged from $19.30 to $31.77, leaving it in the upper half of its 52-week range (75%). Reported volume for the session was 864.9K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Arcutis raises 2026 net revenue guidance to $525M-$540M as ZORYVE demand expands and telehealth launches — See source for full details.
Loading $ARQT research…